BioCentury | Feb 8, 2008
Financial News

Point Biomedical raises $25 million

...expected to close next quarter. Additional investors included Amberbrook; CHL Medical Partners; De Novo Ventures; Fininvest...
BioCentury | Aug 23, 2004
Finance

Follow the money

...Cardiosphere. Investors in the round were Anvers; CHL Medical Partners; De Novo Ventures; Frazier Healthcare; Fininvest...
BioCentury | Aug 19, 2004
Financial News

Point Biomedical raises $27.1M

...III trials in March. Investors included Anvers; CHL Medical Partners; De Novo Ventures; Frazier Healthcare; Fininvest...
BioCentury | Apr 8, 2002
Finance

Ebb & Flow

...expand its pipeline of imaging and drug delivery products. Investors were Invesco Private Capital; Anvers; Fininvest...
BioCentury | Apr 5, 2002
Financial News

Point Biomedical raises $23.3 million

...Carlos, Calif.) raised $23.3 million in a venture financing. Investors included Invesco Private Capital; Anvers; Fininvest...
Items per page:
1 - 5 of 5
BioCentury | Feb 8, 2008
Financial News

Point Biomedical raises $25 million

...expected to close next quarter. Additional investors included Amberbrook; CHL Medical Partners; De Novo Ventures; Fininvest...
BioCentury | Aug 23, 2004
Finance

Follow the money

...Cardiosphere. Investors in the round were Anvers; CHL Medical Partners; De Novo Ventures; Frazier Healthcare; Fininvest...
BioCentury | Aug 19, 2004
Financial News

Point Biomedical raises $27.1M

...III trials in March. Investors included Anvers; CHL Medical Partners; De Novo Ventures; Frazier Healthcare; Fininvest...
BioCentury | Apr 8, 2002
Finance

Ebb & Flow

...expand its pipeline of imaging and drug delivery products. Investors were Invesco Private Capital; Anvers; Fininvest...
BioCentury | Apr 5, 2002
Financial News

Point Biomedical raises $23.3 million

...Carlos, Calif.) raised $23.3 million in a venture financing. Investors included Invesco Private Capital; Anvers; Fininvest...
Items per page:
1 - 5 of 5